Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 1,155,349	$ 3,662,615
Accounts receivable	219,618
Other assets	117,728	43,391
Total current assets	1,492,695	3,706,006
Long-term assets
Property and equipment - net	220,765	206,810
Deferred compensation		416,666
Right of use asset - operating	460,705	544,670
Security deposit	17,004	17,004
Total long-term assets	698,474	1,185,150
Total assets	2,191,169	4,891,156
Current liabilities
Accounts payable	249,880	195,381
Notes payable	738,985	1,000,001
Notes payable CARES Act PPP Loan		24,189
Due to related parties	50,000	50,000
Operating lease liability - current	104,117	76,227
Accrued expenses	10,807	21,870
Accrued dividends	48,079	48,079
Subscription payable	585,000
Total current liabilities	1,786,868	1,415,747
Long-term liabilities
Operating lease liability - non-current	425,339	507,188
Total long-term liabilities	425,339	507,188
Total liabilities	2,212,207	1,922,935
Stockholders’ Equity (Deficit)
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at September 30, 2022 and December 31, 2021 (Liquidation preference $340,050 and $340,050, respectively)	14	14
Common stock, $.001 par value, 500,000,000 shares authorized; 207,817,878 and 207,562,461 shares issued and outstanding at September 30, 2022 and at December 31, 2021, respectively	207,817	207,562
Additional paid-in capital	101,728,483	100,452,862
Accumulated deficit	(101,957,353)	(97,692,217)
Total Stockholders’ Equity (Deficit)	(21,038)	2,968,221
Total Liabilities and Stockholders’ Equity (Deficit)	$ 2,191,169	$ 4,891,156